Porat Daniel,Dukhno Oleg,Cvijic Sandra V,Dahan Arik (2025) Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass, BIOMOLECULES, vol. 15, br. 7, str. - (Article) 

Porat Daniel,Dukhno Oleg,Cvijic Sandra V,Dahan Arik (2024) Erectile Dysfunction Therapy of Bariatric Patients: Tadalafil Biopharmaceutics and Pharmacokinetics Before vs. After Gastric Sleeve/Bypass, AAPS JOURNAL, vol. 26, br. 6, str. - (Article) 

Porat Daniel,Dukhno Oleg,Cvijic Sandra V,Dahan Arik (2023) The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass, PHARMACEUTICS, vol. 15, br. 12, str. - (Article) 

Porat Daniel,Dukhno Oleg,Partook-Maccabi Mazal,Vainer Ella,Cvijic Sandra V,Dahan Arik (2023) Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics, INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 645, br. , str. - (Article) 

Porat Daniel,Dukhno Oleg,Vainer Ella,Cvijic Sandra V,Dahan Arik (2022) Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery, MOLECULAR PHARMACEUTICS, vol. , br. , str. - (Article; Early Access)